RNA-Based Multiplexing Assay for Routine Testing of Fusion and Splicing Variants in Cytological Samples of NSCLC Patients

 RNA-Based Multiplexing Assay for Routine Testing of Fusion and Splicing Variants in Cytological Samples of NSCLC Patients

The detection of ALK receptor tyrosine kinase (ALK), ROS proto-oncogen1, receptor tyrosine kinase (ROS1), ret proto-oncogen (RET), and MET proto-oncogen exon 14 skipping (<i>MET</i>Δ<i>ex14</i>) allows for the selection of specific kinase inhibitor treatment in patients with...

Full description

Bibliographic Details
Main Authors: Cristina Aguado, Ana Giménez-Capitán, Ruth Román, Sonia Rodríguez, Núria Jordana-Ariza, Andrés Aguilar, Carlos Cabrera-Gálvez, Carlos Rivas-Corredor, Pilar Lianes, Santiago Viteri, Irene Moya, Miguel A. Molina-Vila
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Diagnostics
Subjects:
cytology
nCounter
NSCLC
Online Access:https://www.mdpi.com/2075-4418/11/1/15

Internet

https://www.mdpi.com/2075-4418/11/1/15

Similar Items